Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

LIG3 antibody (AA 823-922)

This anti-LIG3 antibody is a Mouse Polyclonal antibody detecting LIG3 in WB and ELISA. Suitable for Human.
Catalog No. ABIN561672

Quick Overview for LIG3 antibody (AA 823-922) (ABIN561672)

Target

See all LIG3 Antibodies
LIG3 (Ligase III, DNA, ATP-Dependent (LIG3))

Reactivity

  • 44
  • 17
  • 17
  • 4
  • 4
  • 3
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
Human

Host

  • 43
  • 1
Mouse

Clonality

  • 43
  • 1
Polyclonal

Conjugate

  • 28
  • 3
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This LIG3 antibody is un-conjugated

Application

  • 30
  • 15
  • 9
  • 7
  • 6
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB), ELISA
  • Binding Specificity

    • 9
    • 7
    • 5
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 823-922

    Purpose

    Mouse polyclonal antibody raised against a partial recombinant LIG3.

    Sequence

    TKSSPVKVGE KRKAADETLC QTKVLLDIFT GVRLYLPPST PDFSRLRRYF VAFDGDLVQE FDMTSATHVL GSRDKNPAAQ QVSPEWIWAC IRKRRLVAPC

    Cross-Reactivity

    Human

    Characteristics

    Antibody Reactive Against Recombinant Protein.

    Immunogen

    LIG3 (NP_039269, 823 a.a. ~ 922 a.a) partial recombinant protein with GST tag.
  • Application Notes

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    50 % glycerol

    Handling Advice

    Aliquot to avoid repeated freezing and thawing.

    Storage

    -20 °C

    Storage Comment

    Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
  • Target

    LIG3 (Ligase III, DNA, ATP-Dependent (LIG3))

    Alternative Name

    LIG3

    Background

    Full Gene Name: ligase III, DNA, ATP-dependent
    Synonyms: LIG2

    Gene ID

    3980

    NCBI Accession

    NM_013975

    Pathways

    DNA Damage Repair
You are here:
Chat with us!